By SmokerBar Editorial Team

If you’re an adult smoker wondering whether switching to VELO nicotine pouches is actually healthier than continuing to smoke cigarettes, you’ve come to the right place. The question matters — not just for your health, but for making an informed choice.

The short answer is yes — based on a growing body of 2025–2026 scientific evidence, VELO nicotine pouches are substantially healthier than continuing to smoke cigarettes, provided you switch completely. The key differences are fundamental: cigarettes burn tobacco, releasing thousands of harmful chemicals through combustion. VELO pouches contain no tobacco leaf and involve no combustion whatsoever. The nicotine is absorbed through the oral mucosa — not inhaled into the lungs — eliminating exposure to tar, carbon monoxide, and the vast majority of carcinogens found in cigarette smoke.

As the reference article you provided states: “VELO nicotine pouches do not contain tobacco or other carcinogens. While they carry the same risk of addiction, VELO pouches do not cause cancer. Compared to cigarettes, VELO nicotine pouches are safe when used properly.”

In this 2026 guide, we’ll break down exactly why VELO is healthier than smoking — from toxicant reduction and cancer risk to real‑world health outcomes — so you can make an informed decision.

The Fundamental Difference: Combustion vs. No Combustion

The most important distinction between VELO and cigarettes is simple: VELO involves no combustion.

Cigarette smoke contains over 7,500 individual chemicals. Of these, more than 60 are known carcinogens (substances that can cause cancer) — including tar, carbon monoxide, formaldehyde, benzene, and tobacco‑specific nitrosamines (TSNAs). These chemicals are by‑products of burning tobacco. They are inhaled deep into the lungs, where they damage delicate tissue, cause inflammation, and over time lead to lung cancer, COPD, emphysema, and heart disease.

VELO nicotine pouches, in contrast, contain no tobacco leaf and require no combustion. They are made from high‑quality ingredients: water, plant‑based materials, flavourings, sweeteners, and pharmaceutical‑grade nicotine. Nothing is burned. Nothing is inhaled. The nicotine is absorbed directly through the oral mucosa into the bloodstream — bypassing the lungs entirely.

As VELO’s official comparison explains: “With smoking, tobacco is burned, and it is the process of combustion that produces more than 7,500 individual chemicals found in smoke. Of the >7,500 individual chemicals produced, more than 60 are known carcinogens (can cause cancer); however, nicotine is not one of these and it is not carcinogenic.”

Toxicant Reduction: 99% Fewer Harmful Chemicals

The numbers behind VELO’s health advantage are striking. Independent laboratory testing commissioned by VELO compared the levels of 9 key toxicants in cigarette smoke — selected by the World Health Organisation Study Group on Tobacco Product Regulation — against the contents of VELO nicotine pouches.

The results show that VELO pouches contain 99% fewer toxicants than a cigarette. This comparison is based on “an assessment of smoke from a scientific standard reference cigarette (approximately 9mg tar) and components released during use of a VELO pouch, in terms of the average of the 9 components the World Health Organisation recommends to reduce in cigarette smoke.”

Importantly, VELO clarifies: “99% less toxicants does not mean that VELO is 99% less risky than cigarettes and VELO contains nicotine, an addictive substance.” The claim refers specifically to toxicant levels — not overall health risk. But the elimination of combustion means VELO users are not exposed to tar, carbon monoxide, or the vast majority of carcinogens found in cigarette smoke.

Cancer Risk: VELO Does Not Cause Cancer

One of the most important health distinctions between VELO and cigarettes is cancer risk. As the reference article correctly notes, “VELO nicotine pouches do not contain tobacco or other carcinogens. While they carry the same risk of addiction, VELO pouches do not cause cancer.”

This aligns with VELO’s official position that nicotine itself “is not carcinogenic (does not have potential to cause cancer).” The vast majority of carcinogens in cigarette smoke come from combustion — not from nicotine. By eliminating combustion entirely, VELO removes the primary source of cancer‑causing chemicals found in cigarette smoke.

However, it’s worth noting that independent studies have found trace amounts of tobacco‑specific nitrosamines (TSNAs) in some nicotine pouches, though BAT states they are not found in “quantifiable” levels. Long‑term epidemiological studies on exclusive nicotine pouch use are still ongoing, but the existing evidence strongly supports a significantly lower cancer risk compared to continued smoking.

Independent Research: What the 2025–2026 Studies Show

The 99% toxicant reduction claim is not just marketing — it’s supported by rigorous independent research.

CORESTA Toxicant Analysis (2025)

A 2025 CORESTA study compared 132 analytes across 11 oral nicotine pouches (including nine VELO products), two snus products, and cigarette smoke. The results are compelling: 70 analytes were not quantified in any nicotine pouch samples tested. A higher number of analytes were present in snus (n = 58) than in nicotine pouches (n = 47). In most tests, the nicotine pouches contained lower levels of analytes (>90%) than snus. All nicotine pouches tested did not exceed the GOTHIATEK® standard’s maximum allowable limits established for snus — the same standard considered in the FDA’s MRTP authorisation for General Snus products. The study concluded that “the results support the hypothesis that ONPs might offer a potentially reduced risk profile alternative to smoking.”

Abuse Liability Study (2025)

A 2025 peer‑reviewed study published in Frontiers in Pharmacology evaluated the abuse liability (addiction potential) of VELO oral nicotine pouches compared to cigarettes and NRT gum. The findings are significant: mean product liking scores for all VELO ONPs were significantly lower than cigarettes (p < 0.0042), regardless of nicotine level, pouch size, or flavour, but similar to NRT gum. Nicotine uptake with VELO ONPs was slower (longer Tmax) and had lower peak nicotine levels (Cmax) than cigarettes but was comparable or slightly lower than NRT gum. The study concluded: “Velo ONPs demonstrated an AL profile lower than cigarettes and similar to NRT gum, suggesting a reduced potential for abuse compared to cigarettes.”

Pharmacokinetics Meta‑Analysis (2025)

A 2025 meta‑analysis published in Drug and Alcohol Dependence Reports summarised the evidence on nicotine pouch pharmacokinetics. The analysis found that 4 mg pouches delivered 91.73% of cigarette total nicotine exposure, but with a peak nicotine concentration of only 69.15% compared to cigarettes. Critically, peak nicotine concentration was “consistently achieved earlier with cigarettes (5‑8 min) than with pouches (20‑65 min).” This slower, more gradual absorption curve means VELO delivers satisfying nicotine levels without the sharp spikes that make cigarettes so reinforcing and addictive.

Real‑World Health Outcomes: BAT’s Clinical Studies

British American Tobacco (BAT) has conducted multiple studies to assess the real‑world health impact of VELO use compared to cigarette smoking.

A cross‑sectional clinical study — the first VELO study to evaluate levels of specific biomarkers of exposure to tobacco toxicants and biomarkers of potential harm relevant to smoking‑related diseases — found that VELO consumers had “significantly better results for several indicators linked to smoking‑related diseases compared with smokers.”

BAT has stated that “we have already generated data that shows Velo has a toxicant profile better than snus and comparable to Nicotine Replacement Therapy (NRT).” This positions VELO alongside medically approved cessation aids in terms of its toxicological profile — not as a cessation aid itself, but as a substantially less harmful alternative for adult smokers who switch completely.

Sharon Goodall, Head of Regulatory Science at British American Tobacco, explained: “Our generated data shows that Velo’s toxicity characteristics are better than snuff and comparable to nicotine replacement therapies. However, we hope to produce further evidence to prove its significant contribution to reducing tobacco harm.”

FDA Position: Lower‑Risk Alternative

While VELO itself has not yet received FDA authorisation (applications remain pending as of April 2026), the FDA has clearly stated its position on nicotine pouches generally. The agency considers nicotine pouches a “lower‑risk alternative” to cigarettes and other traditional tobacco products.

Medscape reported in January 2026 that “the FDA positions these as lower‑risk alternatives to smoked tobacco.” Hayden McRobbie, PhD, a professor of public health at Queen Mary University of London, told Medscape: “On the risk continuum, nicotine pouches are likely less harmful than cigarettes and vaping for people who already smoke. That’s because they eliminate tobacco leaf and the inhalation of aerosols containing flavorants and aldehydes.”

In December 2025, the FDA authorised six nicotine pouch products under the on! PLUS brand — the first outcome of a pilot program launched to streamline the review process for nicotine pouch applications, following the January 2025 authorisation of 20 Zyn products. The FDA said its evaluation found the products to contain “lower levels of most harmful and potentially harmful constituents than other oral and smokeless tobacco products.”

What Makes VELO Different from Cigarettes?

Here’s a side‑by‑side comparison of key health factors:

The Snusdaddy comparison notes that “cigarettes are inherently riskier than tobacco‑free nicotine pouches like VELO. An average cigarette contains 8000 chemicals and 70+ carcinogens.” VELO contains none of these combustion‑related carcinogens.

Important Caveats: What “Healthier” Does NOT Mean

While VELO is significantly healthier than cigarettes, it’s important to understand what this does NOT mean.

VELO Is Not Risk‑Free

VELO still contains nicotine, which is addictive and carries cardiovascular risks. As VELO’s own product information states: “This product is not risk‑free and contains nicotine, an addictive substance.”

A December 2025 expert consensus report in the European Heart Journal concluded that nicotine is a direct cardiovascular toxin — increasing heart rate, raising blood pressure, and damaging blood vessels. VELO eliminates combustion‑related toxins but does not eliminate nicotine’s cardiovascular effects.

VELO Is Not a Smoking Cessation Aid

VELO is not FDA‑approved as a smoking cessation aid. As the manufacturer clearly states: “They are not marketed or licenced as smoking aids or devices.”

However, for adult smokers who cannot or will not quit nicotine entirely, switching completely to VELO represents a meaningful harm reduction step.

Complete Switching Required

The health benefits of VELO only apply if you switch completely. Dual use — continuing to smoke while also using pouches — does not provide the same health benefits. The studies cited above specifically examined exclusive VELO use compared to continued smoking.

Long‑Term Data Still Emerging

Because nicotine pouches are relatively new, long‑term epidemiological studies are still ongoing. A 2025 narrative review noted that “limited preliminary studies suggest reduced toxicant exposure compared to combustible tobacco, but the long‑term health effects are still unknown.”

Who Should Use VELO? (And Who Should Not)

Based on the 2025–2026 evidence, here is clear guidance:

VELO may be appropriate for:

• Adult smokers (18+ or 21+ depending on local laws) who have tried to quit using other methods and would otherwise continue smoking

• Adults who understand that nicotine is addictive and carries cardiovascular risks

• Adults who will switch completely from cigarettes (not dual use)

VELO is NOT appropriate for:

• Anyone under the legal age (nicotine harms developing brains)

• Non‑nicotine users of any age

• Pregnant or breastfeeding women

• Individuals with heart disease, high blood pressure, or diabetes without consulting a doctor

• Anyone who would use VELO while continuing to smoke or vape

As VELO’s official guidance states: “VELO nicotine pouches are not risk‑free and are addictive.”

The Bottom Line: A Clear Health Advantage

Based on the totality of 2025–2026 scientific evidence — from toxicant analysis, clinical studies, abuse liability research, and FDA regulatory review — the answer is clear:

VELO nicotine pouches are substantially healthier than continuing to smoke cigarettes for adult smokers who switch completely.

The evidence supporting this conclusion includes:

• 99% fewer toxicants compared to cigarette smoke, based on WHO‑recommended testing

• 70 analytes not quantified in any nicotine pouch samples tested

• 90% lower analyte levels in nicotine pouches compared to snus

• No combustion — eliminating tar, carbon monoxide, and 60+ carcinogens

• Lower abuse liability than cigarettes, similar to NRT gum

• Slower nicotine absorption (20‑65 minutes vs. 5‑8 minutes), reducing reinforcing spikes

• FDA classification as a “lower‑risk alternative” to smoked tobacco

However, VELO is not risk‑free. Nicotine is addictive and carries cardiovascular risks. Long‑term epidemiological data is still emerging, though existing evidence is encouraging. The product is intended exclusively for adult smokers who would otherwise continue smoking — not for non‑users, minors, or pregnant women.

As the reference article correctly states: “VELO nicotine pouches do not contain tobacco or other carcinogens. While they carry the same risk of addiction, VELO pouches do not cause cancer. Compared to cigarettes, VELO nicotine pouches are safe when used properly.”

If you are an adult smoker who has tried to quit but continues to smoke, switching completely to VELO represents a meaningful step toward reducing your exposure to harmful chemicals. The healthiest choice of all, if you can achieve it, is to quit nicotine entirely. But for those who cannot or will not, VELO offers a scientifically supported, substantially healthier alternative to continued cigarette smoking.

Shop Authentic VELO Nicotine Pouches at SmokerBar

At SmokerBar, we carry the full range of authentic VELO nicotine pouches — from 4 mg to 17 mg — in all your favourite flavours: Freezing Peppermint, Ruby Berry, Purple Grape, Bright Spearmint, Tropical Mango, and more. All products are sourced directly from authorised distributors, stored fresh, and shipped discreetly with age verification (18+ or 21+ depending on local laws).

Browse our VELO collection today — and make a healthier choice for your future.

Disclaimer: This product contains nicotine. Nicotine is an addictive chemical. For adult nicotine users aged 18+ only. This article is for informational purposes and does not constitute medical advice. “99% fewer toxicants” refers to levels of 9 WHO‑recommended toxicants compared to cigarette smoke, not overall health risk. If you do not use nicotine, do not start. Keep out of reach of children and pets. If you smoke cigarettes, quitting altogether is the healthiest choice. Switching to VELO is a less harmful alternative for adult smokers who would otherwise continue smoking.